LiverSource »  Faculty »  Radiation Oncology »  Albert J. Chang M.D., Ph.D.
Albert J. Chang M.D., Ph.D.

Albert J. Chang M.D., Ph.D.

Assistant Professor in Residence
Department of Radiation Oncology

Contact Information

Helen Diller Family Comprehensive Cancer Center 
Box 1708, 1600 Divisadero St, MZ Bldg R H1031
San Francisco, CA 94143 - 1708
Voice: 415-353-7175
Fax: 415-353-9883 
Open Popup
  • 1997 UC Davis BS (SCL) Biochemistry
  • 2007 Boston University School of Medicine, Boston, MA MD/PhD
  • 2008 Kaiser Permanente Oakland, Oakland, CA Internship
  • 2012 Washington University School of Medicine, Saint-Louis, MO Resident Radiation Therapy
  • American Board of Radiology
  • Brachytherapy
  • Bronchioloalveolar Carcinoma (BAC)
  • Chemoradiation
  • Electron beam and orthovoltage irradiation
  • External-beam radiation therapy
  • Gastrointestinal Malignancies
  • Genitourinary Malignancies
  • Gynecologic malignancies
  • Hepatocellular Carcinoma (Liver Cancer)
  • Intensity-modulated radiation therapy
  • Liver Metastases
  • Non-Small Cell Lung Cancer
  • Small-Cell Lung Cancer

Dr. Albert Chang specializes in radiation therapy for treatment of genitourinary malignancies, gastrointestinal malignancies, and gynecologic malignancies. He has expertise in modern radiation techniques such as stereotactic body radiotherapy, Cyberknife radiosurgery, brachytherapy, and intensity modulated radiation therapy. 

Dr. Chang received his Ph.D. in molecular medicine and his M.D. from Boston University School of Medicine in 2007. He completed his residency in radiation oncology at the Washington University School of Medicine. His research interests are in the development of molecular imaging probes and targeted therapies. He has developed multiple imaging agents with the ability to characterize tumors at the cellular level. These imaging agents have the potential to be used for defining disease extent, predicting treatment response, and optimizing therapy. He is also involved in the design of clinical trials investigating the advanced imaging technologies, radiation therapy techniques, and targeted drug therapies that allow for the maximization of therapeutic effect while minimizing treatment side effects.

Most recent publications from a total of 32
  1. Kunogi H, Cunha JAM, Chang AJ, Gadzinski AJ, Shinohara K, Hsu IC. A novel urethral sparing technique for high-dose-rate prostate brachytherapy after transurethral resection of the prostate. Brachytherapy. 2017 Aug 28. View in PubMed
  2. Paulsson AK, Yom SS, Anwar M, Pinnaduwage D, Sudhyadhom A, Gottschalk AR, Chang AJ, Descovich M. Respiration-Induced Intraorgan Deformation of the Liver. Technol Cancer Res Treat. 2017 Jan 01; 1533034616687193. View in PubMed
  3. Choi JY, Yang J, Noworolski SM, Behr S, Chang AJ, Simko JP, Nguyen HG, Carroll PR, Kurhanewicz J, Seo Y. (18)F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons. Radiology. 2016 Aug 11; 160220. View in PubMed
  4. Zhang L, Johnson J, Gottschalk AR, Chang AJ, Hsu IC, Roach M, Seymour ZA. Receiver operating curves and dose-volume analysis of late toxicity with stereotactic body radiation therapy for prostate cancer. Pract Radiat Oncol. 2017 Mar - Apr; 7(2):e109-e116. View in PubMed
  5. Baumann BC, Bosch WR, Bahl A, Birtle AJ, Breau RH, Challapalli A, Chang AJ, Choudhury A, Daneshmand S, El-Gayed A, Feldman A, Finkelstein SE, Guzzo TJ, Hilman S, Jani A, Malkowicz SB, Mantz CA, Master V, Mitra AV, Murthy V, Porten SP, Richaud PM, Sargos P, Efstathiou JA, Eapen LJ, Christodouleas JP. Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy. Int J Radiat Oncol Biol Phys. 2016 Sep 1; 96(1):78-86. View in PubMed
  6. Raleigh DR, Chang AJ, Tomlin B, Cunha JA, Braunstein SE, Shinohara K, Gottschalk AR, Roach M, Hsu IC. Patient- and treatment-specific predictors of genitourinary function after high-dose-rate monotherapy for favorable prostate cancer. Brachytherapy. 2015 Nov-Dec; 14(6):795-800. View in PubMed
  7. Jalloh M, Leapman MS, Cowan JE, Shinohara K, Greene KL, Roach M, Chang AJ, Chan JM, Simko JP, Carroll PR. Patterns of Local Failure following Radiation Therapy for Prostate Cancer. J Urol. 2015 Oct; 194(4):977-82. View in PubMed
  8. Seymour ZA, Chang AJ, Zhang L, Kirby N, Descovich M, Roach M, Hsu IC, Gottschalk AR. Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer. Pract Radiat Oncol. 2015 Sep-Oct; 5(5):e465-72. View in PubMed
  9. Raleigh DR, Hsu IC, Braunstein S, Chang AJ, Simko JP, Roach M. Bladder wall recurrence of prostate cancer after high-dose-rate brachytherapy. Brachytherapy. 2015 Mar-Apr; 14(2):185-8. View in PubMed
  10. Chang AJ. Editorial comment. Urology. 2014 Dec; 84(6):1387-8. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Albert J. Chang M.D., Ph.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.